Capital Analysts, LLC Astrazeneca PLC Transaction History

Capital Analysts, LLC

  • $2.26 Billion
  • Q2 2024

A detailed history of Capital Analysts, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital Analysts, LLC holds 479 shares of AZN stock, worth $36,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares
479
Previous 460 4.13%
Holding current value
$36,030
Previous $31,000 22.58%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$66.81 - $80.83 $1,269 - $1,535
19 Added 4.13%
479 $38,000
Q1 2024

May 14, 2024
BUY
$61.03 - $69.57 $5,126 - $5,843
84 Added 22.34%
460 $31,000
Q3 2023

Nov 13, 2023
BUY
$64.85 - $71.7 $194 - $215
3 Added 0.8%
376 $25,000
Q1 2023

May 05, 2023
BUY
$63.15 - $71.6 $315 - $358
5 Added 1.36%
373 $26,000
Q4 2022

Feb 08, 2023
SELL
$54.21 - $70.44 $5,475 - $7,114
-101 Reduced 21.54%
368 $25,000
Q3 2022

Nov 14, 2022
BUY
$53.02 - $135.75 $11,028 - $28,236
208 Added 79.69%
469 $26,000
Q1 2022

May 12, 2022
BUY
$55.72 - $67.12 $222 - $268
4 Added 1.56%
261 $17,000
Q3 2021

Nov 04, 2021
SELL
$55.56 - $60.79 $2,333 - $2,553
-42 Reduced 14.05%
257 $15,000
Q2 2021

Nov 15, 2021
SELL
$48.42 - $60.18 $26,631 - $33,099
-550 Reduced 64.78%
299 $18,000
Q2 2021

Aug 05, 2021
BUY
$48.42 - $60.18 $26,631 - $33,099
550 Added 183.95%
849 $51,000
Q1 2021

May 17, 2021
BUY
$47.16 - $54.44 $12,025 - $13,882
255 Added 579.55%
299 $15,000
Q4 2020

Feb 16, 2021
BUY
$48.52 - $58.02 $2,134 - $2,552
44 New
44 $2,000
Q1 2019

May 13, 2019
SELL
$35.49 - $43.02 $638 - $774
-18 Closed
0 $0
Q1 2018

May 14, 2018
SELL
$32.97 - $36.63 $565,534 - $628,314
-17,153 Reduced 99.9%
18 $1,000
Q4 2017

Feb 12, 2018
BUY
$32.09 - $34.78 $551,017 - $597,207
17,171
17,171 $1.23 Million

Others Institutions Holding AZN

# of Institutions
1,343
Shares Held
492M
Call Options Held
4.99M
Put Options Held
3.19M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email